ArticleAnnals of hematology2025

From pharmacokinetic-guided FVIII prophylaxis to low-dose Emicizumab prophylaxis: a pilot study revealed a flush of hope.

Juan Ye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.